Drugmaker Novavax has officially applied for FDA emergency use authorization for its protein-based coronavirus vaccine, according to a Jan. 31 news release.
Read the full post on Becker's Hospital Review - Healthcare News
Novavax submits COVID-19 vaccine for FDA authorization
